Holen Sie sich die Stockscreener-App
3.26
1.56%
0.05
Handel nachbörslich:
3.16
-0.10
-3.07%
Schlusskurs vom Vortag:
$3.21
Offen:
$3.2
24-Stunden-Volumen:
24,597
Relative Volume:
0.41
Marktkapitalisierung:
$2.76M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.66M
KGV:
-0.321
EPS:
-10.156
Netto-Cashflow:
$-11.09M
1W Leistung:
-0.91%
1M Leistung:
+5.84%
6M Leistung:
-55.81%
1J Leistung:
-72.77%
1-Tages-Spanne:
$3.05
$3.33
1-Wochen-Bereich:
$2.91
$3.35
52-Wochen-Spanne:
$2.40
$18.81
Phio Pharmaceuticals Corp Stock (PHIO) Company Profile
Firmenname
Phio Pharmaceuticals Corp
Sektor
Branche
Telefon
(508) 767-3861
Adresse
11 APEX DRIVE, SUITE 300A, MARLBOROUGH, MA
Phio Pharmaceuticals Corp Stock (PHIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-08-05 | Eingeleitet | H.C. Wainwright | Buy |
Phio Pharmaceuticals Corp Aktie (PHIO) Neueste Nachrichten
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Quantisnow
Phio Pharmaceuticals Announces Upcoming Presentation at the 39th - Shoreline Beacon
Phio Pharmaceuticals Announces Upcoming Presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - Newsfile
TSX 60 Index (TXSX) QuotePress Release - The Globe and Mail
Correction to Registration Link to Access Phio Pharmaceuticals' Presentation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Newsfile
Financial Analysis: Dianthus Therapeutics (NASDAQ:DNTH) and Phio Pharmaceuticals (NASDAQ:PHIO) - Defense World
Nasdaq Financial 100 Index (IXF) QuotePress Release - The Globe and Mail
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-deal Roadshow Series - StockTitan
Phio Pharmaceuticals presents novel cancer therapy data - Investing.com
Phio Pharmaceuticals presents novel cancer therapy data By Investing.com - Investing.com South Africa
Phio Pharmaceuticals Presenting Data on Its INSTAYL Compound PH-894 at ASGCT's 2024 Advancing Gene and Cell Therapies for Cancer Conference - Yahoo Finance
Understanding the Risks of Investing in Phio Pharmaceuticals Corp (PHIO) - Knox Daily
Phio Pharmaceuticals Announces Presentation at the 9th Annual CAR-TCR Summit in Boston, MA - MSN
Phio Announces Data Showcasing INTASYL's Role in Helping Immune Cells Target and Kill Cancer Cells - Newsfile
Phio Pharmaceuticals (NASDAQ:PHIO) Shares Down 2.5% – Time to Sell? - Defense World
Phio Pharmaceuticals Announces Upcoming Presentation at ASGCT's 2024 Advancing Gene + Cell Therapies for Cancer Conference - Yahoo Finance
Nu Holdings Ltd Cl A (NU-N) QuotePress Release - The Globe and Mail
PHIOPhio Pharmaceuticals Corp. Latest Stock News & Market Updates - StockTitan
This trade activity should not be overlooked: Hyliion Holdings Corporation (HYLN) - SETE News
INTASYL Technology and Compounds to be Focus of Presentation at 20th - North Bay Nugget
INTASYL Technology and Compounds to be Focus of Presentation at 20th Annual Meeting of Oligonucleotide Therapeutics Society - Newsfile
HITE Hedge Asset Management LLC Sells 12,931 Shares of PHINIA Inc. (NYSE:PHIN) - MarketBeat
Dow Jones Industrials Average (DOWI) QuotePress Release - The Globe and Mail
Hyliion Holdings Corporation (HYLN) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Down 4% - MarketBeat
Financial Metrics Unveiled: P3 Health Partners Inc (PIII)’s Key Ratios in the Spotlight - The Dwinnex
Does Hyliion Holdings Corporation (NYSE: HYLN) Still Need To Convince Analysts? - Stocks Register
Barrow Hanley Mewhinney & Strauss LLC Purchases Shares of 898,419 Helios Technologies, Inc. (NASDAQ:HLIO) - MarketBeat
Hancock Whitney Corp Buys 10,920 Shares of PHINIA Inc. (NYSE:PHIN) - MarketBeat
PHINIA Inc. (NYSE:PHIN) Shares Acquired by Long Road Investment Counsel LLC - Defense World
King Luther Capital Management Corp Boosts Position in Helios Technologies, Inc. (NASDAQ:HLIO) - Defense World
Texas Permanent School Fund Corp Has $1.39 Million Stock Holdings in PHINIA Inc. (NYSE:PHIN) - Defense World
Thailand's new celebrity baby pygmy hippo, Moo Deng - The Business Standard
Bokf Na Has $58,000 Stock Position in Haleon plc (NYSE:HLN) - Defense World
American Century Companies Inc. Raises Position in PHINIA Inc. (NYSE:PHIN) - Defense World
Contrasting Clearmind Medicine (NASDAQ:CMND) and Phio Pharmaceuticals (NASDAQ:PHIO) - Defense World
Phio Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Devon Dispatch
Phio Pharmaceuticals (NASDAQ:PHIO) Trading Down 0.8% - Defense World
Finanzdaten der Phio Pharmaceuticals Corp-Aktie (PHIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Phio Pharmaceuticals Corp-Aktie (PHIO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Bitterman Robert J | President & CEO |
Jun 06 '24 |
Buy |
0.75 |
1,000 |
750 |
19,990 |
| Bitterman Robert J | President & CEO |
Feb 26 '24 |
Buy |
0.91 |
2,500 |
2,275 |
18,990 |
2.02%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):